# Dclk1 LLC

Canonical: https://abierto.us/vendors/dclk1-llc-j7nhej9jfxd5

- UEI: J7NHEJ9JFXD5
- CAGE: 80EU9
- Location: Kansas City, MO
- Awards in window: 1 (2 transactions), $0 obligated, January 26, 2024 to June 14, 2024

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91023C00008 (definitive contract): $0, NIH NCI. SBIR Concept Award-Nanosponge Linked Dclk1 Inhibitors for the Targeted Treatment of Cholangiocarcinoma. https://www.usaspending.gov/award/CONT_AWD_75N91023C00008_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/dclk1-llc-j7nhej9jfxd5.